Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Oral Testosterone Esters in Hypogonadal Men
NCT00695110Phase 2Completed
- Sponsor
- Clarus Therapeutics
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testosterone undecanoate and testosterone enanthate in Hypogonadism, sponsored by Clarus Therapeutics. Primary endpoints: Serum Testosterone Average Concentration at 12 hours and Serum Testosterone Area Under Curve (0-24). Started Jun 2008; status: completed.
02
Drugs
testosterone undecanoatetestosterone enanthate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00695110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695110.